Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease over-enrolled to 143 total ...

Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) ("Dogwood" or the "Company"), a development-stage biopharmaceutical company focused on advancing first-in-class, ...

Monogram Technologies Inc. ( NASDAQ: MGRM) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief ...

Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. Currently, all ...

One powerlifter academic may have found a way to build lifelong, full-body strength and stability in a very old and rare source.

Then the participants were asked to perform balance and posture tests under certain circumstances, such as standing with their eyes closed, or standing on soft surfaces. Their body’s center of ...

ID president Jason Sarlanis adds that the competing legal claims of Read’s first trial — a toxic romance ... ones in is critical to creating the balance that we think makes the show.

The company said it's goal is to make an offering in 2H 2026, as it plans to go public as a separate entity that operates ...

Oakfield Badger hasn’t started since mid-December, but looked right up to the mark in winning a trial on soft ground at Newcastle’s Beaumont course only a week ago. Already a fresh and heavy ...

Produced by ElevenLabs and News Over Audio (Noa) using AI narration. Listen to more stories on the Noa app. Khalil, a legal permanent resident of the United States and Palestinian activist who ...

The trial of seven starts on March 11. Another nurse will be tried by jury separately at a later date. The death of Maradona, one of the greatest soccer players of all time, sparked an outpouring ...